Cleared Traditional

K180940 - KODEX EPD System

K180940 is an FDA 510(k) clearance for KODEX EPD System, manufactured by Philips Medical Systems Nederland B.V.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 197-day FDA review.

K180940 · Philips Medical Systems Nederland B.V. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2018
Decision
197d
Days
Class 2
Risk

K180940 is an FDA 510(k) clearance for the KODEX EPD System. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Philips Medical Systems Nederland B.V. (Pc Best, NL). The FDA issued a Cleared decision on October 24, 2018 after a review of 197 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Philips Medical Systems Nederland B.V. devices

FDA 510(k) Submission Details - K180940

510(k) Number K180940 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 10, 2018
Decision Date October 24, 2018
Days to Decision 197 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d slower than avg
Panel avg: 125d · This submission: 197d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 362
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K180940.
AI-ECG Platform
K180432 · Shenzhen Carewell Electronics., Ltd. · Nov 2018
HemoSphere Advanced Monitor, HemoSphere Pressure Cable
K180881 · Edwards Lifesciences, LLC · Nov 2018
CardioInsight Cardiac Mapping System
K181918 · Medtronic, Inc. · Nov 2018
EnSite Velocity Cardiac Mapping System v5.2, EnSite Precision Cardiac Mapping System v2.2
K182644 · Abbott · Oct 2018
Zio AT ECG Monitoring System, ZEUS System
K181502 · iRhythm Technologies, Inc. · Aug 2018
CARTO 3 EP Navigation System, Version 5.2 and Accessories with CARTOFINDER Module
K173978 · Biosense Webster, Inc. · Aug 2018